EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Efficacy of HDAC inhibitors and epigenetic modulation in the amelioration of synovial inflammation, cellular invasion, and bone erosion in rheumatoid arthritis pathogenesis

M Vijaykrishnaraj, Prakash Patil, Sudeep D Ghate, Adithi K Bhandary, Vikram M Haridas, Praveenkumar Shetty

International Immunopharmacology · 2023-09 · 122 · 110644

DOI: 10.1016/j.intimp.2023.110644 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023-09. Verfasst von M Vijaykrishnaraj und 5 weiteren Autor:innen. Beteiligte Einrichtung: Central Research Laboratory, K.S. Hegde Medical Academy, NITTE (Deemed to be University), Deralakatte, Mangaluru 575018, India. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synoviocytes. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA), an auto-immune disorder affected 1 % of the population around the globe. The pathophysiology of RA is highly concerted process including synovial hyperplasia, pannus formation, bone erosion, synovial cell infiltration in joints, and cartilage destruction. However, recent reports suggest that epigenetics play a pivotal role in the formation and organization of immune response in RA. Particularly, altered DNA methylation and impaired microRNA (miRNA) were detected in several immune cells of RA patients, such as T regulatory cells, fibroblast-like synoviocytes, and blood mononuclear cells. All these processes can be reversed by regulating the ubiquitous or tissue-based expression of histone deacetylases (HDACs) to counteract and terminate them. Hence, HDAC inhibitors (HDACi) could serve as highly potent anti-inflammatory regulators in the uniform amelioration of inflammation. Therefore, this review encompasses the information mainly focussing on the epigenetic modulation in RA pathogenesis and the efficacy of HDACi as an alternative therapeutic option for RA treatment. Overall, these studies have reported the targeting of HDAC1, 2 & 6 molecules would attenuate synoviocyte inflammation, cellular invasion, and bone erosion. Further, the inhibitors such as trichostatin A, suberoyl bis-hydroxamic acid, suberoyl anilide hydroxamic acid, and other compounds are found to attenuate synovial inflammatory immune response, clinical arthritis score, paw swelling, bone erosion, and cartilage destruction. Insight to view this, more clinical studies are required to determine the efficacy of HDACi in RA treatment and to unravel the underlying molecular mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSynoviocytesHumansHistone Deacetylase InhibitorsInflammationEpigenesis, GeneticFibroblastsSynovial Membrane

Stichwörter der Autor:innen

Autoimmune diseaseHistone deacetylase inhibitorJoint inflammationRheumatoid arthritisSynovial fibroblasts

Substanzen

Histone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Central Research Laboratory, K.S. Hegde Medical Academy, NITTE (Deemed to be University), Deralakatte, Mangaluru 575018, India.
  • Center for Bioinformatics, K.S. Hegde Medical Academy, NITTE (Deemed to be University), Deralakatte, Mangaluru 575018, India.
  • Department of General Medicine, K.S. Hegde Medical Academy, NITTE (Deemed to be University), Deralakatte, Mangaluru 575018, India.
  • Arthritis Super Speciality Centre, Hubli 580020, Karnataka, India.
  • Central Research Laboratory, K.S. Hegde Medical Academy, NITTE (Deemed to be University), Deralakatte, Mangaluru 575018, India. Electronic address: praveenkumarshetty@nitte.edu.in.

Zitieren

APA

Vijaykrishnaraj, M., Patil, P., Ghate, S. D., Bhandary, A. K., Haridas, V. M., & Shetty, P. (2023). Efficacy of HDAC inhibitors and epigenetic modulation in the amelioration of synovial inflammation, cellular invasion, and bone erosion in rheumatoid arthritis pathogenesis. International Immunopharmacology, 122, 110644. https://doi.org/10.1016/j.intimp.2023.110644

Vancouver

Vijaykrishnaraj M, Patil P, Ghate SD, Bhandary AK, Haridas VM, Shetty P. Efficacy of HDAC inhibitors and epigenetic modulation in the amelioration of synovial inflammation, cellular invasion, and bone erosion in rheumatoid arthritis pathogenesis. International Immunopharmacology. 2023;122:110644. doi:10.1016/j.intimp.2023.110644

BibTeX
@article{Vijaykrishnaraj2023,
  author = {Vijaykrishnaraj, M and Patil, Prakash and Ghate, Sudeep D and Bhandary, Adithi K and Haridas, Vikram M and Shetty, Praveenkumar},
  title = {Efficacy of HDAC inhibitors and epigenetic modulation in the amelioration of synovial inflammation, cellular invasion, and bone erosion in rheumatoid arthritis pathogenesis},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {122},
  pages = {110644},
  doi = {10.1016/j.intimp.2023.110644}
}
Kostenlos starten →